<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01733472</url>
  </required_header>
  <id_info>
    <org_study_id>Hip-CPH-2013</org_study_id>
    <secondary_id>Hässleholm2013</secondary_id>
    <nct_id>NCT01733472</nct_id>
  </id_info>
  <brief_title>General or Regional Anesthesia for Hip Surgery</brief_title>
  <official_title>General Versus Intrathecal Anaesthesia for Patients Undergoing Elective Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether general anaesthesia or regional anaesthesia
      is best for patients undergoing Total Hip Arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled trial (RCT) with a follow up time of 48 hrs. Patients scheduled for
      primary Total Hip Arthroplasty. A total of 120 patients randomly assigned to one of the two
      alternatives (general anaesthesia (GA) or regional anaesthesia (RA)).

      General anaesthesia compared to intrathecal anaesthesia will give shorter length of hospital
      stay (LOS) for patients undergoing total hip arthroplasty (THA).

      Primary endpoint:

      LOS.

      Secondary endpoints:

      Postoperative pain? Postoperative orthostatic function (dizziness) Time until the patient
      meets the discharge criteria from PACU How many patients will need at least one urinary
      bladder catheterisation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Time from the end of surgery until the patients meets the discharge criteria will be evaluated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>from end of surgey until 48 hrs later</time_frame>
    <description>Pain will be monitored using a Visual Analogue Scale. Pain will be monitored with the patient in four different positions</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time until the patient meets the discharge criteria from PACU</measure>
    <time_frame>12 hrs</time_frame>
    <description>Time until the patient meets the discharge criteria from PACU will be monitored every 15 min from teh time the patient arrives to PACU until he/she meets the discharge criteria</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>RA-arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>RA-arm: the patients in this arm will receive intrathecal anaesthesia consisting of bupivacaine 15 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GA-arm, remifentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>GA-arm: patients in this arm will receive general anaesthesia consisting of Target Controlled Infusion (TCI) of remifentanil and propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GA-arm, remifentanil</intervention_name>
    <description>Remifentanil and propofol will be delivered intravenously via TCI pumps according to the &quot;Marsh&quot; and &quot;Minto&quot; algorithm</description>
    <arm_group_label>GA-arm, remifentanil</arm_group_label>
    <other_name>GA: TCI consisting of remifentanil an dpropofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>RA-arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: patients with osteoarthritis scheduled for surgery

          -  patients that will require THA

          -  patients over 45 yrs and under 85 yrs.

          -  patients that understand the given information and are willing to participate in this
             study

          -  patients who have signed the informed consent document.

          -  patients belonging to ASA class I-III.

        Exclusion Criteria:

          -  prior surgery to the same hip

          -  patients with a history of stroke, neurological or psychiatric disease that
             potentially could affect the perception of pain

          -  obesity (BMI &gt; 35)

          -  active or suspected infection

          -  patients taking opioids or steroids

          -  patients suffering from rheumatoid arthritis or an immunological depression

          -  patients who are allergic to any of the drugs being used in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>46 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Harsten, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skane</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept Orthopedic Surgey, Hässleholm Hospital, PO Box 351,</name>
      <address>
        <city>Hässleholm</city>
        <zip>28125</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Fowler SJ, Symons J, Sabato S, Myles PS. Epidural analgesia compared with peripheral nerve blockade after major knee surgery: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2008 Feb;100(2):154-64. doi: 10.1093/bja/aem373. Review.</citation>
    <PMID>18211990</PMID>
  </reference>
  <reference>
    <citation>Marsh BJ, Morton NS, White M, Kenny GN. A computer controlled infusion of propofol for induction and maintenance of anaesthesia in children. Can J Anaesth. 1990 May;37(4 Pt 2):S97.</citation>
    <PMID>2361330</PMID>
  </reference>
  <reference>
    <citation>Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997 Jan;86(1):24-33.</citation>
    <PMID>9009936</PMID>
  </reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2012</study_first_submitted>
  <study_first_submitted_qc>November 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2012</study_first_posted>
  <last_update_submitted>November 5, 2014</last_update_submitted>
  <last_update_submitted_qc>November 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Andreas Harsten</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>anaesthetic techniques</keyword>
  <keyword>subarachnoid</keyword>
  <keyword>analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 7, 2016</submitted>
    <returned>May 11, 2016</returned>
    <submitted>May 12, 2016</submitted>
    <returned>June 21, 2016</returned>
    <submitted>August 15, 2017</submitted>
    <returned>February 16, 2018</returned>
    <submitted>April 10, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

